DNA left at crime scene could be used to create picture of criminal's face, say scientists
By Daily Mail,
Daily Mail
| 02. 17. 2009
Forensic experts will soon be able to reconstruct facial features and skin just by reading DNA, U.S. scientists said.
'Forensic molecular photofitting' maps the genes that are linked to skin pigmentation and facial structure which means a person's face could emerge from the analysis, Dr Mark Shriver from Pennsylvania State University said.
The process has already been used to help identify and convict serial killer Derek Todd Lee who murdered seven women in Louisiana.
Witness statements said the offender was white but genetic testing of DNA at the crime scenes showed he was African American - which helped lead to his arrest.
He was convicted in 2004.
Dr Shriver said he has now linked DNA that mark a person's ethnic origin with the gene mix of fixed points on the face, e.g. corners of the mouth and tip of the nose.
This allows the computer to build up an image of a face based on the gene mix found in the DNA.
Speaking to the American Association for the Advancement of Science in Chicago at the weekend, Dr Shriver said...
Related Articles
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Siddhi Mahatole and Mariam E. Sunny, Reuters | 06.13.2025
Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals' (REGN.O), opens new tab offer for the DNA-testing company in a bankruptcy auction.
Last month, Regeneron agreed to...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...